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  EVIDENCE-BASED ANSWER 
Transvaginal ultrasound should not replace endometrial biopsy for detection of endometrial disease among 
asymptomatic postmenopausal patients. Endometrial biopsy has been considered a standard for the clinical 
diagnosis of endometrial disease among asymptomatic patients, but it is invasive, may be uncomfortable, and 
may not be able to be performed for some patients with cervical stenosis. Ultrasound evaluation is less 
invasive and more comfortable and can be performed for patients with cervical stenosis. The positive predictive 
value of ultrasound is not adequate to allow it to replace endometrial biopsy for screening of asymptomatic 
women (strength of recommendation: B, based on cohort studies). 
  EVIDENCE SUMMARY 
In a trial of postmenopausal estrogen use, 448 asymptomatic postmenopausal women were monitored with 
both endometrial biopsy and transvaginal ultrasound.1 Biopsy detected 11 cases of serious disease. At a 
threshold of 5 mm for endometrial thickness, ultrasound had a positive predictive value of 9% for detecting any 
abnormality with 90% sensitivity and 48% specificity. At this threshold, more than half of women evaluated with 
ultrasound would require endometrial biopsy as well, and only 4% of these patients would have serious 
disease. This study concludes that transvaginal ultrasound has a poor positive predictive value but a high 
negative predictive value for detecting serious endometrial disease for this asymptomatic population. 
An additional study evaluated 1926 asymptomatic postmenopausal women with transvaginal ultrasound.2 Of 
these, 1833 had endometrial thickness <6 mm and 1750 of this cohort underwent biopsy. Five cases of serious 
endometrial abnormality were identified in this group (1 adenocarcinoma and 4 atypical hyperplasia). 
Specificity in this group was 98%, but sensitivity for accurately detecting an abnormality was low at 17%. 
The negative predictive value was greater than 99%. An inadequate number of patients with endometrial 
thickness >6 mm were biopsied (45%) to allow for accurate calculation of positive predictive value in those with 
a >6 mm stripe. The study concludes that transvaginal ultrasonography may not be an effective screening 
procedure for this population. 
The relevance of several other studies is affected by small sample size (range, 36–85).3-6 Other studies did not 
attempt to biopsy all patients screened with ultrasound.7,8 
  RECOMMENDATIONS FROM OTHERS 
The National Cancer Institute states finds the evidence insufficient to recommend any routine screening for 
endometrial cancer with either endometrial biopsy or transvaginal ultrasound. The American Cancer Society 
does not recommend routine screening of asymptomatic patients for endometrial cancer. They recommend 
prompt recognition and evaluation of abnormal uterine bleeding. The US Preventive Services Task Force and 
American Academy of Family Physicians have not issued recommendations related to endometrial cancer 
screening. 
CLINICAL COMMENTARY 
No need to screen postmenopausal women for 
endometrial disease 
 
Paul  V.  Aitken  Jr.,  MD, MPH 
New Hanover Regional Medical Center, Wilmington, NC/University of North Carolina at Chapel 
Hill 
This Clinical Inquiry appears to draw appropriate conclusions to the question as 
presented. However, the question implies tacit approval of the notion of screening 
asymptomatic postmenopausal women. As pointed out above, no major organization 
recommends screening of these women. When reviewing a study we must also ask if the 
original study question is similar to our own clinical question. A critical piece of information 
regarding this answer is that references 1 and 2 are “nested” studies done within the 
context of large drug trials originally designed to answer very different questions. These 
asymptomatic women were being screened as part of the study protocol to ensure drug 
safety. Any effort on our part to apply this data to our asymptomatic patients should be 
considered with this significant limitation in mind. 
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